Charles Schwab
SRRA

Charles Schwab’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Charles Schwab’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,828
Closed -$1.81M – 3607
2022
Q2 		$1.81M Buy
+32,828
New +$1.72M ﹤0.01% 2600

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Charles Schwab's SRRA Position: Q3 2022 in Review

Charles Schwab sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 32,828 shares — an estimated $1.81M sold.

Charles Schwab first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $1.81M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Charles Schwab reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Charles Schwab sold 32,828 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.81M.
  • Charles Schwab first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Charles Schwab's Sierra Oncology, Inc. Common Stock position peaked at $1.81M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.